UniProt ID | TNAP3_MOUSE | |
---|---|---|
UniProt AC | Q60769 | |
Protein Name | Tumor necrosis factor alpha-induced protein 3 | |
Gene Name | Tnfaip3 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 775 | |
Subcellular Localization | Cytoplasm. Nucleus. Lysosome. | |
Protein Description | Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF-alpha and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS-induced production of proinflammatory cytokines and IFN beta in LPS-tolerized macrophages.. | |
Protein Sequence | MAEQLLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIYHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRSVQASLESQKKLNWCREVRKLVALKTNGDGNCLMHAACQYMWGVQDTDLVLRKALCSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLVKMASADTPAARSGLQYNSLEEIHIFVLSNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSQHFVPLVTLKDSGPELRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLIVMEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSDQARRAAHAQNPLEPSTPQLSLMDIKCETPNCPFFMSVNTQPLCHECSERRQKNQSKLPKLNSKLGPEGLPGVGLGSSNWSPEETAGGPHSAPPTAPSLFLFSETTAMKCRSPGCPFTLNVQHNGFCERCHARQINASHTADPGKCQACLQDVTRTFNGICSTCFKRTTAEPSSSLTSSIPASCHQRSKSDPSQLIQSLTPHSCHRTGNVSPSGCLSQAARTPGDRAGTSKCRKAGCMYFGTPENKGFCTLCFIEYRENKQSVTASEKAGSPAPRFQNNVPCLGRECGTLGSTMFEGYCQKCFIEAQNQRFHEARRTEEQLRSSQHRDMPRTTQVASRLKCARASCKNILACRSEELCMECQHLSQRVGSVAHRGEPTPEEPPKQRCRAPACDHFGNAKCNGYCNECYQFKQMYG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEQLLPQA ------CHHHHHHHH | 17.16 | - | |
81 | Ubiquitination | QASLESQKKLNWCRE HHHHHHHHHHHHHHH | 69.38 | - | |
220 | Phosphorylation | KMLRSLESGSNFAPL HHHHHCCCCCCCCCE | 53.46 | 28725479 | |
222 | Phosphorylation | LRSLESGSNFAPLKV HHHCCCCCCCCCEEE | 37.75 | 22942356 | |
376 | Phosphorylation | AQNPLEPSTPQLSLM HCCCCCCCCCCCEEE | 43.26 | 30635358 | |
377 | Phosphorylation | QNPLEPSTPQLSLMD CCCCCCCCCCCEEEE | 26.27 | 30635358 | |
381 | Phosphorylation | EPSTPQLSLMDIKCE CCCCCCCEEEEEEEC | 19.19 | 25266776 | |
437 | Phosphorylation | LPGVGLGSSNWSPEE CCCCCCCCCCCCHHH | 26.07 | 26060331 | |
438 | Phosphorylation | PGVGLGSSNWSPEET CCCCCCCCCCCHHHC | 40.29 | 26060331 | |
441 | Phosphorylation | GLGSSNWSPEETAGG CCCCCCCCHHHCCCC | 27.04 | 26060331 | |
445 | Phosphorylation | SNWSPEETAGGPHSA CCCCHHHCCCCCCCC | 29.01 | 26060331 | |
451 | Phosphorylation | ETAGGPHSAPPTAPS HCCCCCCCCCCCCCC | 45.67 | 26060331 | |
455 | Phosphorylation | GPHSAPPTAPSLFLF CCCCCCCCCCCEEEE | 50.57 | 26060331 | |
458 | Phosphorylation | SAPPTAPSLFLFSET CCCCCCCCEEEEECC | 29.32 | 26060331 | |
498 | Phosphorylation | HARQINASHTADPGK EEEECCCCCCCCCCC | 19.51 | 22942356 | |
500 | Phosphorylation | RQINASHTADPGKCQ EECCCCCCCCCCCHH | 30.20 | 22942356 | |
522 | Phosphorylation | RTFNGICSTCFKRTT HHHCCHHHHHHHCCC | 26.70 | 22942356 | |
523 | Phosphorylation | TFNGICSTCFKRTTA HHCCHHHHHHHCCCC | 19.97 | 22942356 | |
528 | Phosphorylation | CSTCFKRTTAEPSSS HHHHHHCCCCCCCCC | 30.83 | 30635358 | |
529 | Phosphorylation | STCFKRTTAEPSSSL HHHHHCCCCCCCCCC | 32.81 | 22942356 | |
533 | Phosphorylation | KRTTAEPSSSLTSSI HCCCCCCCCCCCCCC | 24.86 | 30635358 | |
534 | Phosphorylation | RTTAEPSSSLTSSIP CCCCCCCCCCCCCCC | 39.83 | 22942356 | |
535 | Phosphorylation | TTAEPSSSLTSSIPA CCCCCCCCCCCCCCH | 39.75 | 22942356 | |
537 | Phosphorylation | AEPSSSLTSSIPASC CCCCCCCCCCCCHHH | 23.52 | 22942356 | |
538 | Phosphorylation | EPSSSLTSSIPASCH CCCCCCCCCCCHHHH | 31.40 | 30635358 | |
539 | Phosphorylation | PSSSLTSSIPASCHQ CCCCCCCCCCHHHHC | 27.62 | 30635358 | |
543 | Phosphorylation | LTSSIPASCHQRSKS CCCCCCHHHHCCCCC | 13.53 | 30635358 | |
548 | Phosphorylation | PASCHQRSKSDPSQL CHHHHCCCCCCHHHH | 29.91 | 27087446 | |
550 | Phosphorylation | SCHQRSKSDPSQLIQ HHHCCCCCCHHHHHH | 56.87 | 27087446 | |
553 | Phosphorylation | QRSKSDPSQLIQSLT CCCCCCHHHHHHHCC | 42.48 | 25266776 | |
558 | Phosphorylation | DPSQLIQSLTPHSCH CHHHHHHHCCCCCCC | 27.50 | 28725479 | |
563 | Phosphorylation | IQSLTPHSCHRTGNV HHHCCCCCCCCCCCC | 16.90 | 28725479 | |
567 | Phosphorylation | TPHSCHRTGNVSPSG CCCCCCCCCCCCCCC | 14.94 | 25619855 | |
571 | Phosphorylation | CHRTGNVSPSGCLSQ CCCCCCCCCCCHHHH | 19.83 | 25521595 | |
573 | Phosphorylation | RTGNVSPSGCLSQAA CCCCCCCCCHHHHHC | 34.33 | 25619855 | |
577 | Phosphorylation | VSPSGCLSQAARTPG CCCCCHHHHHCCCCC | 23.11 | 25619855 | |
616 | Phosphorylation | CTLCFIEYRENKQSV EEEEEEEECCCCCCC | 20.57 | - | |
622 | Phosphorylation | EYRENKQSVTASEKA EECCCCCCCCHHHHC | 24.05 | 28285833 | |
628 | Ubiquitination | QSVTASEKAGSPAPR CCCCHHHHCCCCCCC | 56.40 | - | |
631 | Phosphorylation | TASEKAGSPAPRFQN CHHHHCCCCCCCCCC | 23.81 | - | |
683 | Phosphorylation | RTEEQLRSSQHRDMP HHHHHHHHHCCCCCC | 42.83 | 25266776 | |
684 | Phosphorylation | TEEQLRSSQHRDMPR HHHHHHHHCCCCCCH | 24.46 | 30387612 | |
707 | Ubiquitination | KCARASCKNILACRS HHHHHHCCHHHHHCC | 44.52 | - | |
714 | Phosphorylation | KNILACRSEELCMEC CHHHHHCCHHHHHHH | 34.99 | 30387612 | |
730 | Phosphorylation | HLSQRVGSVAHRGEP HHHHHHHHHHCCCCC | 17.18 | 25266776 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TNAP3_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TNAP3_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TNAP3_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SSBP2_MOUSE | Ssbp2 | physical | 20211142 | |
SSBP3_MOUSE | Ssbp3 | physical | 20211142 | |
MED16_MOUSE | Med16 | physical | 20211142 | |
TRAF6_MOUSE | Traf6 | physical | 17703191 | |
TAXB1_MOUSE | Tax1bp1 | physical | 20185725 | |
UB2D3_MOUSE | Ube2d3 | physical | 20185725 | |
RIPK1_MOUSE | Ripk1 | physical | 21765415 | |
TAXB1_MOUSE | Tax1bp1 | physical | 21765415 | |
NEMO_MOUSE | Ikbkg | physical | 24859449 | |
UBC_MOUSE | Ubc | physical | 23602765 | |
RIPK1_MOUSE | Ripk1 | physical | 23602765 | |
TNAP3_MOUSE | Tnfaip3 | physical | 23602765 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...